Stock Analiz

Precipio, Inc. PRPO

Biotechnology: Laboratory Analytical Instruments · data as of November 13, 2026

$22.13Market cap $40M
Open the interactive analysis →

Precipio, Inc. (PRPO) is a industrial company listed in the US with a market value of about $40M. In the twelve months to September 30, 2026 it had revenue of $28M and net income of -$1M, a net margin of -4.1%.

Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: a price to free cash flow of 28.6, 5-year revenue growth of 26% a year, a 5-year average ROIC of -40%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 40% below the current price.

About Precipio

Precipio is listed in the US and classified in biotechnology: laboratory analytical instruments. Revenue went from $1M in 2014 to $24M in 2025, growth of about 30.9% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 41% over three years (dilution for shareholders). It spends 7% of revenue on research and development.

Score: 2.0 / 5

Value0/5
Future growth4/5
Track record1/5
Financial health4/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Debt below 3 years of free cash flow

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF28.6
P/S1.4
P/B2.7
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield3.5%
Shareholder yield0.0%
Intrinsic value vs. price−40%

Growth and quality

Revenue growth (1 yr)29.8%
Revenue growth (5 yrs, per year)26.5%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-56.8%
ROIC (5-yr avg.)-40.0%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$28M$24M$19M$15M$10M$9M$7M$4M$3M$2M$2M
Net income-$1M-$363000-$4M-$6M-$12M-$9M-$14M-$13M-$16M-$21M-$2M
Free cash flow$1M$359000$216000-$4M-$8M-$7M-$8M-$9M-$7M-$7M-$978000
EPS (diluted)$-0.59$-0.23$-2.93$-4.51$-10.73$-8.00$-17.00$-46.60$-276.40$-2148.00$-2832.00
Net margin-4.1%-1.5%-23.2%-38.5%-124.3%-96.4%-188.0%-323.4%-455.2%-1017.9%-129.2%
ROIC—-7.0%-32.7%-49.5%-73.2%-37.5%-59.1%-76.6%-185.0%-74.5%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Precipio stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 40% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Precipio pay a dividend?

Not currently.

Is Precipio a good stock to buy?

We do not give buy or sell advice. Precipio scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.